GRHL2 Gene Deafness Autosomal Dominant Type 28 NGS Genetic DNA Test
Introduction to the Test
The GRHL2 Gene Deafness Autosomal Dominant Type 28 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies genetic mutations associated with hereditary hearing loss. This test employs Next Generation Sequencing (NGS) technology to analyze the GRHL2 gene, which plays a crucial role in the development of the auditory system. Understanding your genetic predisposition to hearing loss can be vital for early intervention and management.
What the Test Measures
This genetic test specifically detects mutations in the GRHL2 gene that are linked to autosomal dominant deafness. By identifying these mutations, healthcare providers can better understand the underlying causes of hearing loss in affected individuals.
Who Should Consider This Test?
This test is recommended for individuals with:
- A family history of hearing loss or deafness.
- Symptoms of hearing impairment, such as difficulty understanding speech or sounds.
- Risk factors associated with genetic hearing loss.
Consultation with an ENT doctor or a genetic counselor is advised to determine if this test is appropriate for you.
Benefits of Taking the Test
Taking the GRHL2 Gene Deafness Autosomal Dominant Type 28 NGS Genetic DNA Test offers several benefits:
- Accurate identification of genetic predispositions to hearing loss.
- Informed decision-making regarding family planning and management of hearing loss.
- Access to targeted therapies and interventions.
- Peace of mind for individuals and families regarding their genetic health.
Understanding Your Results
Results from this test will provide insights into whether a mutation is present in the GRHL2 gene. A positive result indicates a genetic predisposition to hearing loss, while a negative result suggests that the individual does not carry the mutation. It is essential to discuss your results with a healthcare professional who can guide you on the next steps.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| GRHL2 Gene Deafness Autosomal Dominant Type 28 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Sample Type and Turnaround Time
The test requires a sample of blood, extracted DNA, or one drop of blood on an FTA card. Results are typically available within 3 to 4 weeks.
Pre-Test Instructions
Before undergoing the test, patients should have a clinical history reviewed by a healthcare provider, who may also recommend a genetic counseling session to discuss family history and draw a pedigree chart.
Book Your Test Today!
DNA Labs Kenya has branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. We also offer home sample collection services for your convenience. Contact us now to book your GRHL2 Gene Deafness Autosomal Dominant Type 28 NGS Genetic DNA Test or call/WhatsApp us at +254746849631.
